arrow
P

Peter Burgard

centre for paediatric and adolescent medicine
H指数:46
被引数:7,235

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correspondence on “Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)” by Smith et al

关于“苯丙氨酸羟化酶缺乏症的诊断与管理:美国医学遗传学与基因组学学院(ACMG)2023年循证临床指南”的通信,由Smith等人撰写

2026-01-060
PRE
Transition for adolescents with a rare disease: results of a nationwide German project

患有罕见疾病的青少年的过渡: 德国全国性项目的结果

2023-04-2510
OAAI
An Integrated clinical pathway for diagnosis, treatment and care of rare diseases: model, operating procedures, and results of the project TRANSLATE-NAMSE funded by the German Federal Joint Committee

罕见疾病的诊断,治疗和护理的综合临床路径: 模型,操作程序和由德国联邦联合委员会资助的项目TRANSLATE-NAMSE的结果

2021-11-129
OAAI
Long-term Outcomes of Individuals With Metabolic Diseases Identified Through Newborn Screening

通过新生儿筛查确定的代谢性疾病个体的长期结果

2020-11-0146
PREAI
Impact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders
2019-05-1349
OAAI
Decreased plasma L-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: Options for treatment
2019-04-0125
PREAI
Biallelic Mutations in NBAS Cause Recurrent Acute Liver Failure with Onset in Infancy
2015-07-01110
OAAI
Visual functions in phenylketonuria-evaluating the dopamine and long-chain polyunsaturated fatty acids depletion hypotheses

苯丙酮尿症的视觉功能-评估多巴胺和长链多不饱和脂肪酸耗竭假设

2013-01-0112
PREAI